Cervical adenocarcinoma in situ

Area of Science:

• Gynecology
• Oncology
• Pathology

Background:

• Cervical adenocarcinoma in situ (AIS) is a rare precursor to invasive cervical adenocarcinoma.
• Understanding the clinical and pathological characteristics of AIS is crucial for appropriate management.
• This study reviews a cohort of patients diagnosed with AIS.

Purpose of the Study:

• To report on the clinical characteristics and pathological data of 18 patients with cervical adenocarcinoma in situ.
• To compare the demographic and clinical features of AIS with invasive cervical adenocarcinoma.
• To evaluate the efficacy of cone biopsy margins in predicting disease status.

Main Methods:

• Retrospective review of 18 patients diagnosed with cervical adenocarcinoma in situ at a single institution.
• Analysis of clinical presentation, pathological findings, and treatment outcomes.
• Comparison of patient demographics and disease characteristics with historical data for invasive cervical adenocarcinoma.

Main Results:

• Cervical adenocarcinoma in situ represented 9.2% of all endocervical adenocarcinomas during the study period.
• The median age for AIS was 37 years, significantly younger than for invasive disease (47 years).
• Abnormal bleeding was the presenting symptom in 60% of patients. Cone biopsy margins accurately predicted disease in 10 of 12 cases.
• One patient experienced recurrent adenocarcinoma and died 16 years post-diagnosis.

Conclusions:

• Cervical adenocarcinoma in situ is a distinct entity with a younger median age at diagnosis compared to invasive disease.
• Cone biopsy margin assessment is a valuable tool, but not infallible, in managing AIS.
• Hysterectomy with pelvic lymph node evaluation is suggested as a potentially curative treatment approach for cervical adenocarcinoma in situ.